Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The purpose of this project is to appoint a supplier to handle the receipt of clinical trial Investigational Medicinal Product (IMP) from manufacturer, import, labelling, and distribution to the in-country sites/teams.
The trial will be running in Brazil and Ghana and involves two oral medications. Initial dose will be delivered to remote community clinic or ambulance vehicle (field) and subsequent doses stored and given from the hospital site during the participant admission.
To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=955202089
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot LW140 Sept 2025 – Sept 2028 | - | planning |